BIOMAT Database Logo BIOMAT Database Logo

Hydralazine and beta-adrenergic blockade in the treatment of hypertension. 1974

L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010096 Oxprenolol A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety. Coretal,Koretal,Oxprenolol Hydrochloride,Slow Trasicor,Tevacor,Trasicor,Hydrochloride, Oxprenolol,Trasicor, Slow
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Beta adrenergic blockade in hypertension.
October 1976, The Journal of the Association of Physicians of India,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Beta-adrenergic blockade in hypertension.
March 1977, American heart journal,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
[Beta adrenergic receptor blockade in the treatment of arterial hypertension].
January 1976, Kardiologia polska,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.
June 1974, British heart journal,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Combined alpha and beta adrenergic blockade in treatment of hypertension.
May 1973, British heart journal,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Hypertension, exercise, and beta-adrenergic blockade.
October 1988, Annals of internal medicine,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Alpha and beta adrenergic blockade in hypertension.
May 1972, Lancet (London, England),
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Combined treatment of hypertension with vasodilatation and beta-adrenergic blockade.
October 1973, Michigan medicine,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.
March 1972, Circulation,
L Siitonen, and J Jänne, and O Keyriläinen, and P Koskinen, and O Leskinen, and T Pitkäjärvi, and M Reinikainen
The paradox of beta-adrenergic blockade in hypertension.
March 1968, Circulation,
Copied contents to your clipboard!